Teleflex Future Growth

Future criteria checks 2/6

Teleflex is forecast to grow earnings and revenue by 17.9% and 5.1% per annum respectively. EPS is expected to grow by 19.1% per annum. Return on equity is forecast to be 11.8% in 3 years.

Key information

17.9%

Earnings growth rate

19.1%

EPS growth rate

Medical Equipment earnings growth	16.2%
Revenue growth rate	5.1%
Future return on equity	11.8%
Analyst coverage	Good
Last updated	06 May 2024

Recent future growth updates

Recent updates

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Feb 19

Is Teleflex (NYSE:TFX) A Risky Investment?

Feb 02

Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult

Jan 17

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Dec 31

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Nov 13

We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt

Oct 29

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Oct 13

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Oct 13

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Sep 27

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Aug 07

Teleflex: Flexing Its Muscles A Bit

Jul 27

Is Teleflex (NYSE:TFX) A Risky Investment?

Jul 20

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Jul 05

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

Jun 22

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Jun 20

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

May 05

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Apr 17

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Mar 31

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Mar 14

Teleflex's 2 catheter devices get FDA clearance

Feb 22

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Jan 27

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Jan 12

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Jan 11

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

Dec 28

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Dec 12

Teleflex recalls over 2.7M bacterial filters – FDA

Nov 01

Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy

Oct 25

Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)

Oct 17

Is Teleflex (NYSE:TFX) Using Too Much Debt?

Oct 03

Is Teleflex Incorporated (NYSE:TFX) Trading At A 44% Discount?

Sep 05

Teleflex to acquire Standard Bariatrics for $170M

Aug 22

Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching

Aug 08

Telefex: Valuations Are Stretched, Lack Of Risk Premia To Harvest

Jul 25

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

Jul 12

Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate

Jul 01

Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?

Jun 27

Earnings and Revenue Growth Forecasts

NYSE:TFX - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	3,441	615	725	847	10
12/31/2025	3,260	543	633	731	15
12/31/2024	3,089	409	614	635	15
3/31/2024	3,001	296	430	538	N/A
12/31/2023	2,974	358	419	511	N/A
10/1/2023	2,959	405	381	471	N/A
7/2/2023	2,899	369	326	412	N/A
4/2/2023	2,860	363	278	366	N/A
12/31/2022	2,791	363	264	344	N/A
9/25/2022	2,795	412	373	445	N/A
6/26/2022	2,808	510	421	488	N/A
3/27/2022	2,817	488	537	603	N/A
12/31/2021	2,810	485	580	651	N/A
9/26/2021	2,759	434	565	645	N/A
6/27/2021	2,687	351	479	567	N/A
3/28/2021	2,540	280	468	559	N/A
12/31/2020	2,537	336	346	436	N/A
9/27/2020	2,507	367	307	389	N/A
6/28/2020	2,527	479	327	413	N/A
3/29/2020	2,612	551	265	364	N/A
12/31/2019	2,595	462	337	440	N/A
9/29/2019	2,556	442	318	427	N/A
6/30/2019	2,517	269	317	416	N/A
3/31/2019	2,475	183	326	415	N/A
12/31/2018	2,448	196	357	437	N/A
9/30/2018	2,402	66	331	404	N/A
7/1/2018	2,327	89	332	404	N/A
4/1/2018	2,246	170	342	416	N/A
12/31/2017	2,146	155	N/A	420	N/A
10/1/2017	2,065	259	N/A	427	N/A
7/2/2017	1,986	246	N/A	425	N/A
4/2/2017	1,931	227	N/A	432	N/A
12/31/2016	1,868	237	N/A	408	N/A
9/25/2016	1,828	267	N/A	426	N/A
6/26/2016	1,816	262	N/A	373	N/A
3/27/2016	1,795	248	N/A	326	N/A
12/31/2015	1,799	236	N/A	301	N/A
9/27/2015	1,798	197	N/A	255	N/A
6/28/2015	1,808	191	N/A	276	N/A
3/29/2015	1,821	194	N/A	287	N/A
12/31/2014	1,827	190	N/A	287	N/A
9/28/2014	1,802	174	N/A	301	N/A
6/29/2014	1,759	164	N/A	292	N/A
3/30/2014	1,711	159	N/A	264	N/A
12/31/2013	1,685	151	N/A	228	N/A
9/29/2013	1,656	147	N/A	187	N/A
6/30/2013	1,613	125	N/A	160	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TFX's forecast earnings growth (17.9% per year) is above the savings rate (2.4%).

Earnings vs Market: TFX's earnings (17.9% per year) are forecast to grow faster than the US market (14.4% per year).

High Growth Earnings: TFX's earnings are forecast to grow, but not significantly.

Revenue vs Market: TFX's revenue (5.1% per year) is forecast to grow slower than the US market (8.3% per year).

High Growth Revenue: TFX's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TFX's Return on Equity is forecast to be low in 3 years time (11.8%).

Teleflex Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024

Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023

Teleflex Incorporated Updates Earnings Guidance for the Year 2023

Teleflex Incorporated Provides Earnings Guidance for the Year 2023

Price target decreased to US$248

Price target decreased to US$248

Recent updates

First quarter dividend of US$0.34 announced

Teleflex Incorporated Announces Quarterly Cash Dividend, Payable on June 14, 2024

Teleflex: Compelling, Despite Some Operational Hiccups

Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?

Teleflex Incorporated, Annual General Meeting, May 03, 2024

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Fourth quarter dividend of US$0.34 announced

Full year 2023 earnings: EPS misses analyst expectations

Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024

Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate

Is Teleflex (NYSE:TFX) A Risky Investment?

Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult

Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Chairman notifies of intention to sell stock

Executive VP & CFO exercised options and sold US$1.4m worth of stock

Teleflex Incorporated Announces First Patient Enrollment in ACCESS-MANTA Registry

Teleflex Incorporated Announces A New Peer-Reviewed Study in the Nature Journal Prostate Cancer and Prostatic Diseases Confirms the Position of the UroLift System as the Gold Standard in Minimally Invasive Surgical Treatment

Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes

Teleflex Incorporated Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt

Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Teleflex Shares Hit Hard As Growth Concerns Stack Up

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Teleflex Incorporated (NYSE:TFX) acquired Palette Life Sciences for $650 million.

Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?

Teleflex Incorporated Announces Extension of Arrow ErgoPack Complete System to Hemodialysis and Large Bore Central Venous Catheters

Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return

Upcoming dividend of US$0.34 per share at 0.6% yield

Teleflex Incorporated Updates Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Teleflex Incorporated Receives FDA Clearance for Expanded Indication for QuikClot Control+(TM) Hemostatic Device Usage in Cardiac Surgical Procedures

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB for $650 million.

Teleflex Incorporated (NYSE:TFX) entered into a definitive agreement to acquire Palette Life Sciences AB from Östersjöstiftelsen, Endowment Arm, Praktikerinvest AB and Recipharm Venture Fund AB for $650 million.

Teleflex: Flexing Its Muscles A Bit

Is Teleflex (NYSE:TFX) A Risky Investment?

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price

Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Teleflex Incorporated Receives FDA Clearance for the Wattson Temporary Pacing Guidewire

Teleflex Incorporated Announces the Arrow(R) EZ-Io(R) Needle Is Now FDA Cleared for Use in an MRI Environment

Independent Director notifies of intention to sell stock

Teleflex Announces Quarterly Dividend, June 15, 2023

Teleflex Incorporated Provides Earnings Guidance for the Year 2023

Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued

These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well

Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price

At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?

Full year 2022 earnings: EPS misses analyst expectations

Teleflex's 2 catheter devices get FDA clearance

Independent Director exercised options and sold US$161k worth of stock

Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns

Chairman exercised options and sold US$1.0m worth of stock

Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Chairman notifies of intention to sell stock

An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued

What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?

Price target decreased to US$248

Insufficient new directors

Upcoming dividend of US$0.34 per share

Teleflex Incorporated Announces Worldwide Recall of Affected Lots of Gibeck Iso-Gard Filter Products

Teleflex recalls over 2.7M bacterial filters – FDA

Price target decreased to US$248